Robert Zimmer Insider Profile

4 Followers
Robert Zimmer, President & Chief Science Officer, Ten Percent Owner at ImmuPharma, holds 27.34M shares in ImmuPharma (Ticker: GB:IMM). Most recently, Robert Zimmer Bought 2,000,000p shares of ImmuPharma on Mar 30, 2020 for an estimated value of 200.00K.
tipranks
Robert Zimmer

Robert Zimmer
ImmuPharma (IMM)
President & Chief Science Officer, Ten Percent Owner

Ranked #30,477 out of 99,218 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+50.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

£454K
100.00%
A breakdown of Robert Zimmer's holdings

Insider Roles

ImmuPharma
(IMM)
President & Chief Science Officer, Ten Percent Owner
Roles that Robert Zimmer holds in companies

Most Profitable Insider Trade

Stock:
ImmuPharma
(IMM)
Rating:Informative Buy
Date:Feb 05, 2016 - Feb 05, 2017
Return:+115.60%
The most profitable trade made by Robert Zimmer

Robert Zimmer's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ImmuPharma
Mar 30, 2020
President & Chief Science Officer, Ten Percent Owner
Informative Buy
200.00K
£453.92K
Success Rate for
IMM
1 out of 2 profitable transactions on
IMM
50%
Average Return for
IMM
Average return per transaction on
IMM
+50.65%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Mar 30, 2020
Informative Buy
£200.00K
-
£10.00
-14.30%
Feb 05, 2016
Informative Buy
£320.00K
-
£26.00
+115.60%
List of latest transactions for each holding click on a transaction to see Robert Zimmer's performance on stock

Robert Zimmer insider profile FAQ

What is the percentage of profitable transactions made by Robert Zimmer?
The percentage of profitable transactions made by Robert Zimmer is 50%.
    What is the average return per transaction made by Robert Zimmer?
    The average return per transaction made by Robert Zimmer is 50.60%.
      What stocks does Robert Zimmer hold?
      Robert Zimmer holds: GB:IMM stocks.
        What was Robert Zimmer’s latest transaction?
        Robert Zimmer latest transaction was an Informative Buy of 200.00K.
          What was Robert Zimmer's most profitable transaction?
          Robert Zimmer’s most profitable transaction was an Informative Buy of GB:IMM stock on February 5, 2016. The return on the trade was 115.60%.
            What is Robert Zimmer's role in ImmuPharma?
            Robert Zimmer's role in ImmuPharma is President & Chief Science Officer, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.